Tempest Therapeutics, Inc. Proceeds from Issuance of Warrants
Tempest Therapeutics, Inc. (TPST) reported Proceeds from Issuance of Warrants of $3.31 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-30
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2025-12-31 was $1.45M.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2025-09-30 was $0.00.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2024-12-31 was $0.00.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for the quarter ending 2024-09-30 was $0.00.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2025 was $3.31M.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2024 was $0.00.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Tempest Therapeutics, Inc. proceeds from issuance of warrants for fiscal 2022 was $7.28M.
| Period end | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.45M derived: sum of 2 quarters · filed 2026-03-30 | $3.31M 10-K · filed 2026-03-30 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.86M 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | $1.86M 10-Q · filed 2025-08-11 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-11 | |||
| 2023-12-31 | $0.00 10-K · filed 2024-03-19 | |||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $7.28M 10-K · filed 2024-03-19 | |
| 2022-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $7.28M 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $7.28M 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $0.00 derived: sum of 2 quarters · filed 2023-03-22 | $0.00 10-K · filed 2023-03-22 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |